ExSAR Corporation announces that they have entered into a Patent Option Agreement with Brandeis University in Massachusetts.  ExSAR is excited about the opportunity to further research on promising compounds that focus on Amyotrophic Lateral Sclerosis (ALS).

Press Releases | Presentations & Conferences | Publications | Media Coverage | Links